Internal Medicine, Hematology & Oncology · San Leandro, CA
NPI
1366768541
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2500 Merced St, Kaiser Permanente San Leandro Medical Center
San Leandro, CA, 94577
Phone (510) 454-2760
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
2,109 services
Medicare patients, 2024
12
Average age 64
Drug cost, 2024
$10.6M
1,958 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth S Poon prescribed most often to Medicare patients was Lenalidomide, with 341 prescriptions and refills. In total Kenneth S Poon wrote 1,958 Medicare prescriptions that cost $10.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lenalidomide Generic | 341 | 341 | 35 | $3.7M |
| Acyclovir Generic | 253 | 426 | 54 | $5,217 |
| Hydroxyurea Generic | 178 | 372 | 42 | $7,051 |
| Dexamethasone Generic | 168 | 218 | 33 | $2,551 |
| Pomalyst Pomalidomide | 87 | 87 | 13 | $2.1M |
| Prednisone Generic | 59 | 59 | 17 | $492 |
| Brukinsa Zanubrutinib | 57 | 57 | Under 11 | $751K |
| Calquence Acalabrutinib Maleate | 55 | 55 | Under 11 | $790K |
| Entecavir Generic | 47 | 105 | 14 | $1,024 |
| Venclexta Venetoclax | 40 | 40 | 12 | $277K |
| Posaconazole Generic | 32 | 32 | Under 11 | $5,666 |
| Imatinib Mesylate Generic | 32 | 38 | Under 11 | $2,520 |
| Ondansetron Hcl Generic | 29 | 29 | 17 | $238 |
| Jakafi Ruxolitinib Phosphate | 28 | 28 | Under 11 | $362K |
| Tasigna Nilotinib Hcl | 24 | 24 | Under 11 | $239K |
Brand drugs: - claims; generic drugs: 1,458 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kenneth S Poon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.